Abiopharma

🔍 Errico Thomas J. (Director)

Company: electroCore, Inc. (ECOR)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 22,803 shares of Common Stock at $4.35 per share (Direct)
  Date: 2026-03-19 | Code: X | equity_swap_involved: 0 | shares_owned_after: 330,819.00 | transaction_form_type: 4
• Acquired 19,252 shares of Common Stock at $6.43 per share (Direct)
  Date: 2026-03-19 | Code: X | equity_swap_involved: 0 | shares_owned_after: 350,071.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 22,803 shares of Warrants to Purchase Common Stock at $4.35 per share (Derivative)
  Date: 2026-03-19 | Code: X | Expires: 2029-02-02 | Exercise: 2024-02-02 | equity_swap_involved: 0 | transaction_form_type: 4
• Acquired 19,252 shares of Warrants to Purchase Common Stock at $6.43 per share (Derivative)
  Date: 2026-03-19 | Code: X | Expires: 2029-06-05 | Exercise: 2024-06-05 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: Includes 259,106 shares owned directly by the RP; 1,296 shares owned by a trust for the benefit of the RP's family; 11,000 shares owned by a trust for the benefit of the RP; 26,615 unvested shares underlying deferred stock units ("DSUs"); and 52,054 shares that have vested pursuant to previously issued DSUs. All such vested shares were previously reported on Form 4 filings at the time of grant.